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This paper examines adaptive device use among two samples of U.S. adults aged 40 years and older with agerelated macular degeneration, diabetic retinopathy, glaucoma or cataracts from the 2008 and 2016 waves of the
nationally-representative cross-sectional National Health Interview Survey (n = 2875 and n = 6233 respectively). Individuals who replied affirmatively to the question, “do you use any adaptive devices such as telescopic
or other prescriptive lenses, magnifiers, large print or talking materials, CCTV, white cane or guide dogs?” were
defined as adaptive device users. Descriptive statistics and logistic regression models of adaptive device use were
estimated. The main regression models used 2008 data and included explanatory variables for vision-related
limitations, other functional limitations, sociodemographic characteristics and the local availability of ophthalmologists and optometrists. 6.1% of the 2008 sample and 4.2% of the 2016 sample used adaptive devices,
these percentages were significantly different. 31.4% of the 2008 sample and 24.0% of 2016 sample with
multiple vision-related limitations used adaptive devices, these percentages were not significantly different.
Based on previous research, adaptive device use among the subgroups with multiple vision-related limitations
would be expected to improve functional ability. In the regression models, the likelihood of adaptive device use
increased significantly with the number of vision-related limitations, family income and local ophthalmologist
availability. The regression results provide evidence of socioeconomic and geographic disparities in adaptive
device use in the U.S. Together the descriptive statistics and regression results suggest that public health strategies to increase access to adaptive devices are needed.

1. Introduction
Age-related eye diseases such as age-related macular degeneration
(ARMD), diabetic retinopathy, glaucoma and cataracts are leading
causes of visual impairment in the United States (Chou et al., 2013; Eye
Disease Prevalence Research Group, 2004). Visual impairment is associated with a wide array of adverse outcomes including increased difficulty with daily activities, an increased likelihood of depression and
social isolation, and decreased life expectancy (Agency for Healthcare
Research and Quality, 2004; National Academies of Sciences,
Engineering and Medicine, 2016). Vision rehabilitation is intended to
help visually impaired individuals optimize the use of remaining vision.
The vision rehabilitation process typically includes the prescription of
vision assistive equipment (also known as “adaptive devices” or “lowvision aids”) and the provision of other vision rehabilitation services
such as training in the use of adaptive devices, orientation and mobility
training, psychological counseling and occupational therapy (Agency

for Healthcare Research and Quality, 2004; Binns et al., 2012; Morse
et al., 2010; National Academies of Sciences, Engineering and
Medicine, 2016; Owsley et al., 2009).
A 2012 systematic review of English-language studies on the effectiveness of vision rehabilitation services concluded that there was
good evidence that the receipt of vision rehabilitation services improved outcomes related to clinical and functional ability and that the
use of low-vision aids improved reading ability (Binns et al., 2012). A
more recent randomized clinical trial that used a sample of U.S. veterans with macular disease who were visually impaired found that the
receipt of adaptive devices that were prescribed and dispensed by an
optometrist improved functional ability in reading, visual information
processing and visual motor skills (Stelmack et al., 2017).
Goals of the Healthy People 2020 initiative of the U.S. Department
of Health and Human Services include increasing the receipt of vision
rehabilitation services and the use of adaptive devices by individuals
with a visual impairment (U.S. Department of Health and Human
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Table 1
Vision-related characteristics of the 2008 and 2016 Samples of U.S. adults with age-related eye diseases, 2008 and 2016 National Health Interview Surveys.
2008 NHIS sample of adults with an
age-related eye disease
n = 2875
Weighted percentage
(95% CI)
Used adaptive devices, %
6.2 (5.1,7.3)
Age-related eye diseases
ARMD, %
11.9 (10.6, 13.3)
Diabetic retinopathy, %
5.0 (4.1, 6.0)
Glaucoma, %
16.4 (14.7, 18.0)
Cataracts, %
85.3 (83.8, 86.8)
More than one age-related eye disease, %
17.0 (15.3, 18.7)
Lost vision due to an age-related eye disease, %
30.1 (28.1, 32.1)
Even when wearing glasses or contacts it is difficult to
Read, %
17.5 (15.9, 19.1)
See in dim light, %
11.5 (10.1, 12.9)
Drive, %
4.4 (3.5, 5.3)
See peripherally, %
7.6 (6.5, 8.7)
Combination of vision-related difficulties
None, %
77.3 (75.7 79.2)
Reading only difficulty, %
8.5 (7.3, 9.8)
Difficulty other than reading only difficulty, %
4.1 (3.4, 5.0)
Multiple difficulties, %
10.1 (8.9, 11.5)
Combination of vision-related difficulties and adaptive device use among those with
No vision-related limitations, % used adaptive devices
2.3 (1.7, 3.1)
Reading only difficulty, % used adaptive devices
10.0 (6.2, 15.7)
Difficulty other than reading only difficulty, % used adaptive devices
10.4 (5.4, 18.9)
Multiple difficulties, % used adaptive devices
31.4 (24.9, 38.7)
Type of age-related eye disease and adaptive device use among those with
ARMD, % used adaptive devices
16.9 (12.8, 22.0)
ARMD and multiple limitations, % used adaptive devices
44.8 (32.6, 57.6)
Diabetic retinopathy, % used adaptive devices
17.1 (10.5, 26.7)
Diabetic retinopathy and multiple limitations, % used adaptive devices
48.7 (28.6, 69.2)
Glaucoma, % used adaptive devices
6.1 (4.1, 8.8)
Glaucoma and multiple limitations, % used adaptive devices
33.2 (8.7, 32.2)
Cataracts, % used adaptive devices
6.2 (5.1, 7.5)
Cataracts and multiple limitations, % used adaptive devices
17.5 (26.2, 41.1)

2016 NHIS sample of adults with an age-related
eye disease
n = 6233
Weighted percentage
(95% CI)
4.2 (3.6, 4.8)
10.6 (9.6, 11.7)
5.1 (4.3, 5.9)
16.3 (15.1, 17.6)
88.7 (87.6, 89.7)
18.1 (16.9, 19.3)
28.0 (26.5, 29.4)
16.6 (15.4, 17.8)
11.7 (10.6, 12.8)
3.5 (2.9, 4.1)
6.4 (5.6, 7.2)
76.4 (75.0, 77.8)
8.5 (7.7, 9.4)
5.9 (5.2, 6.7)
9.2 (8.3, 10.2)
1.5 (1.1, 2.0)
6.9 (4.7, 9.9)
4.9 (2.4, 9.5)
24.0 (20.1, 28.4)
11.9 (9.2, 15.2)
38.0 (28.3, 48.8)
9.6 (6.4, 14.1)
23.5 (14.3, 35.9)
5.9 (4.5, 7.8)
21.2 (14.6, 29.8)
4.1 (3.5, 4.8)
24.0 (19.8, 28.7)

Abbreviations: ARMD, age-related macular degeneration; CI, confidence interval; NHIS, National Health Interview Survey.

Services, 2010). These goals are based on data from the 2008 National
Health Interview Survey (NHIS). This paper uses data from the 2008
and 2016 waves of the NHIS to examine the use of adaptive devices
among adults aged 40 years and older with age-related eye diseases.
Although these waves of the NHIS asked whether vision rehabilitation
services were used at the time of the survey, vision rehabilitation is not
considered in this paper because < 1% of the 2008 and 2016 samples
with an age-related eye disease reported using vision rehabilitation
services at the time of the survey (n = 30 and n = 41 respectively) and
the sample size is not sufficient for an analysis of the characteristics
associated with the receipt of vision rehabilitations services. The discussion of previous research that follows focuses on the use of adaptive
devices.
Three previous studies examined the rate of adaptive device use
among individuals with ARMD or diabetic retinopathy in the U.S.
(Casten et al., 2005; Schmier et al., 2009; Schmier et al., 2006). These
studies used samples of individuals who were patients at an ophthalmology clinic or participants in an ARMD support group. Two of the
studies did not put a restriction on the age of the individuals in the
sample (Schmier et al., 2009; Schmier et al., 2006) and one study
limited its sample to individuals aged 65 years and older (Casten et al.,
2005). These studies considered a similar set of devices (for example:
white canes, magnifying glasses, telescopic glasses, glasses with special
filters, hand-held magnifiers, hand-held telescopes and guide dogs) and
examined the use of each type of device separately. All three studies
found that magnifiers and telescopes were used most frequently
(around 45% of the samples without age restrictions and 81% of the
older sample used these devices). All three of these studies found that

the use of each type of adaptive device increased as visual acuity decreased. These studies did not consider whether adaptive device use
varied with other individual characteristics. In the one prior study
outside of the U.S., Becker et al. (2005) found that 87% of a sample of
Germans aged 65 years and older who were patients at an ophthalmology clinic and had visual impairment due to ARMD used at least one
type of adaptive device.
This paper adds to the previous research by examining the use of
adaptive devices among two samples of U.S. adults with ARMD, diabetic retinopathy, glaucoma or cataracts from two waves of a nationally
representative survey. It also adds to the prior research by considering
whether a large set of individual and contextual characteristics was
associated with the use of adaptive devices.
2. Methods
2.1. Sample
The empirical analyses used data on adults aged 40 years and older
from the 2008 and 2016 waves of the NHIS. The NHIS is an annual
cross-sectional survey and NHIS samples are designed to be nationally
representative of the U.S. non-institutionalized civilian population.
These waves were chosen for this study because they included supplemental vision health questions for the individual who was the NHIS
“sample adult.” In this paper, age-related eye diseases were defined to
include ARMD, diabetic retinopathy, glaucoma and cataracts. The 2008
NHIS Sample Adult File contains observations on 3059 individuals aged
40 years and older who self-reported having an age-related eye disease;
234
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Table 2
Characteristics of the 2008 Sample of U.S. adults with age-related eye diseases and characteristics of subsamples defined by adaptive device use, 2008 National
Health Interview Survey.
Full sample of adults with an agerelated eye disease
n = 2875
Weighted percentage or mean
(95% CI)
Used adaptive devices, %
6.2 (5.1, 7.3)
Age-related eye diseases
ARMD, %
12.0 (10.6, 13.3)
Diabetic retinopathy, %
5.0 (4.1, 6.0)
Glaucoma, %
16.4 (14.7, 18.0)
Cataracts, %
85.3 (83.8, 86.8)
Combination of age-related eye diseases
ARMD only, %
4.6 (3.7, 5.6)
Diabetic retinopathy only, %
2.4 (1.7, 3.2)
Glaucoma only, %
7.1 (6.0, 8.2)
Cataracts only, %
68.9 (66.9, 70.9)
ARMD & cataracts, %
5.4 (4.4, 6.4)
Diabetic retinopathy & cataracts, %
1.8 (1.2, 2.4)
Glaucoma & cataracts, %
7.6 (6.4, 8.8)
Other combination of age-related eye diseases,
2.2 (1.6, 2.7)
%
Lost vision due to an age-related eye disease, %
30.1 (28.1, 32.1)
Even when wearing glasses or contacts it is difficult to
Read, %
17.5 (15.9, 19.1)
See in dim light, %
11.5 (10.1, 12.9)
Drive, %
4.4 (3.5, 5.3)
See peripherally, %
7.6 (6.5, 8.7)
Combination of vision-related difficulties
None, %
77.3 (75.5, 79.0)
Reading only difficulty, %
8.5 (7.3, 9.8)
Seeing in dim light, driving, or seeing
4.1 (3.4, 5.0)
peripherally only difficulty, %
Multiple difficulties, %
10.1 (8.9, 11.5)
Other functional limitations
Difficulty walking or climbing, %
41.8 (39.7, 44.0)
Difficulty reaching or grasping, %
22.8 (20.7, 24.9)
Hearing difficulties, %
19.2 (17.5, 21.0)
Female, %
62.0 (59.9, 64.1)
Age, mean
70.5 (70.0, 71.1)
Age
40–64, %
28.9 (26.8, 31.1)
65–84, %
59.1 (56.8, 61.4)
85+, %
12.0 (10.5, 13.4)
Education
Less than High School, %
21.5 (19.8, 23.2)
High School or GED, %
32.1 (30.1, 34.1)
Some College, %
24.8 (22.9, 26.7)
College, %
21.1 (19.1, 23.0)
Missing, %
0.5 (0.2, 0.9)
Family income-to-poverty ratio
≤1, %
8.4 (7.3, 9.6)
> 1 and ≤2, %
17.2 (15.5, 19.0)
> 2, %
57.9 (55.6, 60.2)
Missing, %
16.4 (14.7, 18.1)
Race/ethnicity
Non-Hispanic White, %
80.8 (79.0, 82.5)
Non-Hispanic Black, %
8.9 (7.7, 10.0)
Hispanic, %
6.3 (5.4, 7.3)
Other, %
4.0 (3.1, 4.9)
Married, %
54.1 (51.9, 56.4)
Family size, mean
1.98 (1.93, 2.03)
Health insurancea
No health insurance, %
3.1 (2.4, 4.0)
Public insurance only, not including Medicare,
4.1 (3.3, 5.0)
%
Medicare only, %
19.8 (17.9, 21.8)
Medicare and other public ins., %
11.5 (10.2, 13.0)
Medicare and private ins., %
42.3 (40.1, 44.5)
Private insurance only, %
19.3 (17.4, 21.2)
Has a usual place for health care, %
97.3 (96.7, 98.0)
b
Ophthalmologists per 100,000 county residents ,
5.6 (5.3, 6.0)
mean
Optometrists per 100,000 county residents, mean
14.1 (13.6, 14.6)
Tract population density, mean
4007 (3627, 4387)

Adults with an age-related eye disease who
DID NOT use adaptive devices
n = 2700
Weighted percentage or mean (95% CI)

Adults with an age-related eye disease
who DID use adaptive devices
n = 175
Weighted percentage or mean (95% CI)

10.5 (9.2, 12.1)
4.4 (3.6, 5.3)
16.4 (14.8, 18.1)
85.2 (83.6, 86.7)

33.9
14.8
16.7
86.0

4.6 (3.7, 5.7)
2.3 (1.6, 3.2)
7.4 (6.3, 8.6)
70.7 (68.7, 72.8)
4.2 (3.3, 5.3)
1.5 (1.1, 2.0)
7.4 (6.3, 8.7)
1.9 (1.5, 2.5)

4.5 (2.4, 8.2)
4.9 (2.0, 11.7)
2.9 (1.3, 6.6)
40.9 (32.9, 49.4)
23.1 (16.6, 31.1)
7.3 (3.2, 15.6)
10.6 (6.2, 17.5)
5.8 (3.3, 9.9)

27.3 (25.3, 29.3)

72.9 (64.5, 79.9)

14.5 (13.0, 16.1)
9.1 (7.9, 10.5)
3.1 (2.4, 4.0)
5.6 (4.7, 6.8)

63.4
48.1
24.7
37.3

80.5 (78.8, 82.2)
8.1 (7.0, 9.5)
3.9 (3.2, 4.8)

28.4 (21.5, 36.6)
13.6 (8.5, 21.1)
6.9 (3.5, 12.9)

7.4 (6.3, 8.7)

51.1 (42.1, 60.1)

40.0
21.7
18.7
61.7
70.4

69.3
40.6
26.7
66.4
72.5

(37.9,
(19.6,
(17.1,
(59.5,
(69.8,

42.2)
23.8)
20.6)
63.9)
71.0)

(26.1, 41.5)
(8.9, 23.4)
(11.4, 23.9)
(78.9, 91.0)

(54.8,
(39.5,
(17.9,
(29.0,

(60.6,
(32.1,
(19.9,
(58.1,
(70.3,

71.3)
56.9)
33.0)
46.5)

76.8)
49.7)
34.8)
73.7)
74.8)

29.1 (26.9, 31.3)
59.1 (57.3, 61.9)
11.3 (10.0, 12.8)

27.3 (19.8, 36.3)
51.4 (42.3, 60.4)
21.3 (14.9, 29.6)

21.1 (19.4, 22.9)
32.0 (30.0, 34.0)
24.9 (23.0, 27.0)
21.4 (19.5, 23.5)
0.6 (0.3, 1.0)

27.5 (20.2, 36.1)
33.7 (26.0, 42.3)
23.1 (16.7, 31.0)
15.5 (10.5, 22.2)
0.3 (0.04, 2.1)

8.6 (7.5, 9.8)
17.3 (15.5, 19.2)
57.8 (55.4, 60.2)
16.3 (14.7, 18.1)

6.9 (3.5, 13.0)
16.6 (11.7, 23.0)
58.9 (50.3, 67.0)
17.8 (12.4, 24.5)

80.7 (78.8, 82.5)
8.8 (7.7, 10.1)
6.5 (5.5, 7.6)
4.0 (3.2, 5.0)
54.3 (52.0, 56.6)
1.99 (1.93, 2.04)

82.3 (75.6, 87.5)
9.7 (6.3, 14.6)
4.3 (2.3, 8.0)
3.7 (1.4, 9.2)
51.3 (42.7, 59.9)
1.86 (1.71, 2.01)

3.2 (2.4, 4.1)
4.2 (3.3, 5.2)

2.3 (0.6, 7.9)
2.7 (1.2, 5.6)

19.9 (17.9, 21.9)
11.3 (9.9, 12.7)
42.0 (39.8, 44.2)
19.1 (17.7, 21.6)
97.4 (96.6, 98.0)
5.6 (5.3, 6.0)

18.7 (13.1, 26.0)
15.6 (10.2, 23.1)
46.8 (37.8, 55.6)
19.6 (17.7, 21.6)
97.4 (92.3, 99.2)
6.1 (5.2, 7.0)

14.2 (13.7, 14.7)
4045 (3639, 4452)

13.2 (12.1, 14.4)
3425 (2479, 4371)

(continued on next page)
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Table 2 (continued)

Tract median HH income, mean
Region
Northeast, %
Midwest, %
South, %
West, %

Full sample of adults with an agerelated eye disease
n = 2875
Weighted percentage or mean
(95% CI)

Adults with an age-related eye disease who
DID NOT use adaptive devices
n = 2700
Weighted percentage or mean (95% CI)

Adults with an age-related eye disease
who DID use adaptive devices
n = 175
Weighted percentage or mean (95% CI)

54,233 (52,839, 55,627)

54,307 (52,866, 55,750)

53,112 (48,684, 57,539)

18.6
24.9
37.5
19.0

18.7
24.8
37.3
19.2

17.5
25.9
40.6
16.0

(16.4,
(22.3,
(34.8,
(17.1,

20.7)
27.6)
40.2)
20.9)

(16.6,
(22.3,
(34.7,
(17.3,

20.9)
27.6)
40.0)
21.2)

(11.1,
(18.1,
(31.8,
(11.0,

26.6)
35.6)
50.1)
22.6)

Notes
Abbreviations: ARMD, age-related macular degeneration; CI, confidence interval; ins., insurance; HH, household; NHIS, National Health Interview Survey.
Stata “svy” commands with the “subpop” option were used to estimate descriptive statistics that accounted for the complex design features of the NHIS and for the
focus on the subsample of adults with an age-related eye disease. Taylor series linearization was used for variance estimation.
a
The U.S. Medicare program provides health insurance to individuals aged 65 years and older and nonelderly people with a permanent disability. The U.S.
Medicaid program provides health insurance to low-income individuals. Most individuals in the “public insurance only, not including Medicare” and “other public
insurance” categories were participants in the Medicaid program.
b
There are 50 states and 3141 counties in the U.S. The number of counties within U.S. states ranges from 3 (Delaware) to 243 (Texas).

“difficulty grasping or reaching” (difficulty grasping small objects or
reaching overhead) and “hearing impairment” (hearing aid use or
moderate or more severe difficulty hearing).
Demographic and socioeconomic explanatory variables were an
individual's age (40–64 years, 65–84 years, 85 years and above),
gender, educational attainment (less than high school, high school or
Graduate Equivalency Degree, some college, college or more, missing
education), total family income in the previous calendar year divided
by the poverty threshold appropriate to the family's size (< 1, ≥1
and < 2, ≥2, missing) (“family income-to-poverty ratio”), race/ethnicity (white non-Hispanic, black non-Hispanic, Hispanic, other race/
ethnicity), marital status (married, unmarried) and family size.
Explanatory variables measuring ability to access health care were
an individual's health insurance status (see Tables 2 and 3 for insurance
categories) and whether the individual reported having a place they
usually go for routine or preventive care (yes/no). For 2008 NHIS respondents, restricted-access information on the county and census tract
of residence of respondents in 2008 was used to add variables characterizing an individual's area of residence. Geocode information for
2016 NHIS respondents was not available at the time of this study. The
contextual variables included the density of ophthalmologists per capita
and the density of optometrists per capita in the respondent's county of
residence. The county-level number of “patient care” ophthalmologists
in 2008 and the number of optometrists in 2009 was drawn from the
U.S. Department of Health and Human Services Area Health Resources
File (AHRF). Optometrist data from 2008 were not available in the
AHRF. Additional contextual variables were the region in which an
individual resided (Northeast, Midwest, South, West) and the population density and median household income in an individual's census
tract of residence. The 2006–2010 American Community Survey 5-Year
Estimates was the source of county population and tract-level variables.

individuals who self-reported that they were blind (n = 41) or who
were missing information on key variables (n = 143) were excluded
from the analyses, resulting in a 2008 sample of 2875 individuals. The
2016 NHIS Sample Adult File contains observations on 6439 individuals
aged 40 years and older who self-reported having an age-related eye
disease; individuals who were blind (n = 87) or missing information on
key variables (n = 119) were excluded from the analyses, resulting in a
2016 sample of 6233 individuals. Individuals who were blind were
excluded in order to focus on adaptive device use among individuals
with or at high risk of low vision.
2.2. Outcome
2.2.1. Adaptive device use
Respondents were asked if they had trouble seeing even with glasses
or contacts; those who replied affirmatively were asked, “Do you use
any adaptive devices such as telescopic or other prescriptive lenses,
magnifiers, large print or talking materials, CCTV, white cane or guide
dogs?” Individuals who replied “yes” to the adaptive device question
were defined as using adaptive devices and individuals who reported
that they did not have trouble seeing even with glasses or contacts or
who replied that they were not using adaptive devices were defined as
not using adaptive devices.
2.3. Explanatory variables
2.3.1. Vision-related limitations
Respondents were asked if they experienced a set of vision-related
limitations “even while wearing glasses or contacts.” Two approaches
were taken to characterizing an individual's vision-related limitations.
The first approach used indicator variables for “difficulty reading”
(difficulty reading or doing close work), “difficulty in dim light” (difficulty going down steps or curbs at night or in dim light), “difficulty
driving” (difficulty driving during daytime in familiar places) and
“difficulty peripherally” (difficulty noticing objects off to the side while
walking). The second approach used indicator variables to characterize
the combination of visual limitations experienced by an individual
(reading only difficulty (yes/no), visual limitation other than reading
only difficulty (yes/no), multiple types of visual limitations (yes/no),
no visual limitations was the excluded category).

2.4. Statistical analysis
Stata version 15 was used to conduct the empirical analyses. Stata
“svy” commands with the “subpop” option were used to estimate descriptive statistics and logistic regression models that accounted for the
complex design features of the NHIS and for the focus on the subsample
of adults with an age-related eye disease (Korn and Graubard, 1999).
Associations were considered significant if the p-value was 0.05 or
lower.
Weighted descriptive statistics were estimated separately for the
2008 and 2016 samples and for subsamples defined by adaptive device
use. Differences in proportions between the 2008 and 2016 samples
were tested using Z-tests for the equality of two proportions from

2.3.2. Other explanatory variables
Indicator variables were created to measure other functional limitations experienced by an individual. These variables were “difficulty
walking or climbing” (difficulty walking 1/4 mile or climbing 10 steps),
236
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Table 3
Multiple logistic regression models of adaptive device use among U.S. adults with age-related eye diseases, 2008 National Health Interview Survey, n = 2875.
Model (1)

Even when wearing glasses or contacts it is difficult to
Read
Yes
No
See in dim light
Yes
No
Drive
Yes
No
See peripherally
Yes
No
Combination of vision-related difficulties
None
Reading only difficulty
Seeing in dim light, driving, or seeing peripherally only difficulty
Multiple difficulties
Difficult to walk or climb
Yes
No
Difficult to reach or grasp
Yes
No
Hearing difficulties
Yes
No
Gender
Female
Male
Age
40–64
65–84
85+
Education
Less than High School
High School or GED
Some College
College
Missing
Family income-to-poverty ratio
≤1
> 1 and ≤42
>2
Missing
Race/ethnicity
Non-Hispanic White
Non-Hispanic Black
Hispanic
Other
Married
Yes
No
Family size
Health insurance
No health insurance
Public insurance only, not including Medicare
Medicare only
Medicare and other public ins.
Medicare and private ins.
Private insurance only
Has a usual place for health care
Yes
No
Ophthalmologists per 100,000 county residents
Optometrists per 100,000 county residents
Tract population density
Tract median HH income
Region
Northeast
Midwest
South

Model (2)

Odds ratio (95% CI)

Predictive margin (95% CI)

Odds ratio (95% CI)

Predictive margin (95% CI)

4.82 (2.92, 7.97)
1.00 (ref)

13.5 (9.6, 17.3)
3.4 (2.4, 4.4)

2.13 (1.22, 3.73)
1.00 (ref)

9.3 (6.3, 12.3)
5.0 (3.7, 6.7)

1.69 (0.91, 3.17)
1.00 (ref)

8.7 (5.0, 12.4)
5.8 (4.7, 6.9)

1.88 (0.92, 3.85)
1.00 (ref)

9.0 (4.7, 13.3)
5.4 (4.3, 6.6)

–
–
–
–
–
–
–
–
–
–
–

–
–
–
–
–
–
–
–
–
–
–

–
–
–
–

–
–
–
–

1.00 (ref)
4.33 (2.26, 8.31)
4.06 (1.88, 8.76)
17.97 (10.90, 29.69)

2.4 (1.6, 3.1)
9.4 (4.8, 13.9)
8.8 (3.5, 14.2)
28.7 (22.0, 35.4)

1.54 (0.97, 2.42)
1.00 (ref)

7.1 (5.6, 8.6)
5.0 (3.6, 6.5)

1.58 (1.00, 2.51)
1.00 (ref)

7.2 (5.7, 8.6)
4.9 (3.5, 6.4)

1.22 (0.77, 1.95)
1.00 (ref)

6.9 (4.9, 8.8)
5.9 (4.7, 7.0)

1.14 (0.72, 1.81)
1.00 (ref)

6.6 (4.7, 8.6)
6.0 (4.8, 7.1)

1.29 (0.83, 2.00)
1.00 (ref)

7.2 (5.2, 9.2)
5.9 (4.8, 7.0)

1.19 (0.77, 1.86)
1.00 (ref)

6.9 (4.9, 8.8)
6.0 (4.4, 7.8)

1.04 (0.66, 1.63)
1.00 (ref)

6.3 (5.0, 7.5)
6.1 (4.4, 7.8)

1.02 (0.66, 1.59)
1.00 (ref)

6.2 (5.0, 7.4)
6.2 (4.5, 7.8)

1.00 (ref)
0.74 (0.35, 1.57)
0.91 (0.37, 2.27)

7.2 (3.8, 10.5)
5.7 (4.4, 7.0)
6.7 (4.0, 9.4)

1.00 (ref)
0.74 (0.36, 1.49)
1.01 (0.42, 2.46)

7.1 (3.9, 10.3)
5.6 (4.4, 6.8)
7.2 (4.3, 10.0)

1.34
1.36
1.33
1.00
0.73

(0.70,
(0.74,
(0.72,
(ref)
(0.11,

4.71)

6.5
6.5
6.4
5.1
4.0

(4.5, 8.4)
(4.8, 8.3)
(4.5, 8.3)
(3.2, 7.1)
(−1.9, 9.9)

1.40
1.38
1.29
1.00
0.75

(0.75,
(0.79,
(0.72,
(ref)
(0.10,

5.56)

6.7
6.6
6.2
5.1
4.0

(4.6, 8.7)
(4.8, 8.3)
(4.3, 8.1)
(3.3, 6.9)
(−2.5, 10.6)

0.39
0.70
1.00
0.81

(0.16, 0.94)
(0.41, 1.19)
(ref)
(0.48, 1.37)

3.4
5.5
7.1
6.1

(1.1,
(3.6,
(5.7,
(4.0,

5.6)
7.4)
8.6)
8.2)

0.38
0.67
1.00
0.86

(0.16, 0.93)
(0.40, 1.12)
(ref)
(0.51, 1.44)

3.3
5.2
7.2
6.4

(1.0,
(3.5,
(5.7,
(4.3,

5.6)
7.0)
8.7)
8.5)

1.00
1.30
0.58
1.24

(ref)
(0.71, 2.41)
(0.25, 1.35)
(0.35, 4.47)

6.2
7.6
4.0
7.3

(5.1,
(4.4,
(1.4,
(0.4,

7.3)
10.8)
6.6)
14.2)

1.00
1.22
0.54
1.13

(ref)
(0.66, 2.27)
(0.23, 1.23)
(0.31, 4.10)

6.3
7.3
3.8
6.9

(5.2,
(4.1,
(1.3,
(0.1,

7.3)
10.5)
6.3)
13.6)

2.58)
2.44)
2.45)

2.63)
2.41)
2.31)

1.36 (0.80, 2.32)
1.00 (ref)
0.77 (0.56, 1.05)

7.0 (5.2, 8.7)
5.5 (4.1, 6.9)
NA

1.28 (0.78, 2.13)
1.00 (ref)
0.80 (0.60, 1.08)

6.8 (5.1, 8.5)
5.6 (4.3, 7.0)
NA

1.00
0.52
1.38
1.65
1.48
1.07

(ref)
(0.11,
(0.39,
(0.39,
(0.35,
(0.28,

5.0
2.9
6.3
7.3
6.7
5.2

1.00
0.57
1.34
1.69
1.38
1.03

(ref)
(0.12,
(0.30,
(0.41,
(0.34,
(0.27,

5.1
3.2
6.4
7.7
6.5
5.2

0.52
1.00
1.06
0.97
0.99
1.00

(0.14, 1.96)
(ref)
(1.001, 1.12)
(0.94, 1.004)
(0.99, 1.00)
(0.99, 1.00)

6.1 (5.2, 7.1)
9.9 (0.7, 19.2)
NA
NA
NA
NA

0.57
1.00
1.06
0.97
0.99
1.00

(0.14, 2.38)
(ref)
(1.001, 1.11)
(0.95, 1.00)
(0.99, 1.00)
(0.99, 1.00)

6.6 (4.3, 9.0)
6.6 (4.3, 8.8)
6.2 (4.6, 7.8)

1.00 (ref)
0.93 (0.48, 1.78)
0.94 (0.51, 1.71)

2.67)
6.41)
7.05)
6.22)
4.06)

1.00 (ref)
0.97 (0.52, 1.88)
0.91 (0.50, 1.68)

(−0.2, 10.1)
(0.01, 5.7)
(3.8, 8.9)
(4.3, 10.3)
(4.9, 8.5)
(2.4, 8.0)

2.73)
6.07)
7.04)
5.64)
3.88)

(−0.2, 10.4)
(0.3, 6.1)
(3.9, 8.9)
(4.6, 10.7)
(4.8, 8.3)
(2.5, 7.8)

6.2 (5.2, 7.1)
9.3 (−0.2, 18.8)
NA
NA
NA
NA
6.7 (4.2, 9.1)
6.3 (4.1, 8.5)
6.4 (4.7, 8.0)

(continued on next page)
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Table 3 (continued)
Model (1)

West

Model (2)

Odds ratio (95% CI)

Predictive margin (95% CI)

Odds ratio (95% CI)

Predictive margin (95% CI)

0.76 (0.40, 1.42)

5.4 (3.5, 7.2)

0.76 (0.41, 1.41)

5.4 (3.7, 7.1)

Notes
Abbreviations: ARMD, age-related macular degeneration; CI, confidence interval; HH, household; NA, not applicable, NHIS, National Health Interview Survey.
Stata “svy” commands with the “subpop” option were used to estimate logistic regression models that accounted for the complex design features of the NHIS and for
the focus on the subsample of adults with an age-related eye disease. Taylor series linearization was used for variance estimation.
The predictive margin for a category of an explanatory variable is the average over the sample of the predicted probability of device use for each individual calculated
as if the individual was in that category and the remainder of the explanatory variables were equal to the individual's actual values. Predictive margins are useful for
gauging the magnitude of an association between an explanatory variable and a binary outcome variable because the difference in predictive margins between
categories of an explanatory variable shows how much the predicted probability of the outcome changes as the explanatory variable changes. Predictive margins are
presented on a scale from 0 to 100%.

by adaptive device use. The 2008 sample is highlighted because it is the
primary focus of the regression analyses. Those who reported using
adaptive devices were significantly more likely to have ARMD or diabetic retinopathy and were significantly more likely to have more than
one age-related eye disease than those who did not. Additionally, those
who used adaptive devices were significantly more likely to have a
vision-related limitation or other functional limitation and were significantly more likely to have more than one vision-related limitation
than those who did not use adaptive devices.

independent samples. Differences in proportions between subsamples
from the same survey year were tested using Pearson design-based Ftests.
The main logistic regressions models were estimated using 2008
data because it included contextual variables. Model (1) included indicator variables for each type of vision-related limitation and model
(2) included the indicator variables for the combination of visual limitations experienced by an individual. Both models also included the
variables for other functional limitations, sociodemographic characteristics, access to health care and contextual characteristics. Morse
et al. (2010) excluded individuals with cataracts from their estimates of
the prevalence of visual impairment and the need for vision assistive
equipment in the U.S. Medicare population on the grounds that vision
loss from cataracts is potentially reversible through surgery. In sensitivity analyses, models (1) and (2) were estimated excluding individuals
who had cataracts but no other age-related eye diseases. The full set of
models, excluding contextual variables, was also estimated using the
2016 sample. Odds ratios (ORs), predictive margins (PMs), and 95%
confidence intervals (CIs) were calculated. The footnotes to Table 3
provide information about the calculation and interpretation of PMs.
For each set of indicator variables (i.e., combinations of vision-related
limitations), adjusted Wald tests were used to determine whether the
ORs and PMs for the variables in the set were significantly different
from each other.

3.2. Regression analyses
Table 3 presents the results of the logistic regression models using
the 2008 sample. In model (1), difficulty reading and difficulty seeing
in dim light were each associated with a significantly higher likelihood
of adaptive device use relative to not having these difficulties. The
likelihood of adaptive device use differed significantly between the
lowest and highest income categories. Additionally, greater countylevel per capita availability of ophthalmologists was associated with a
significantly higher likelihood of device use. The other explanatory
variables in model (1) were not significantly associated with adaptive
device use.
In model (2), having multiple vision-related limitations was associated with a significantly higher likelihood of adaptive device use relative to having one or no limitations and having one limitation was
associated with a significantly higher likelihood of device use relative
to having no limitations. As in model (1), income and local ophthalmologist availability were significant predictors of adaptive device use
in model (2). The results of models (1) and (2) estimated with a subsample that excluded individuals with cataracts and no other age-related eye diseases were similar to those for the full age-related eye
disease sample (results not shown).
In models (1) and (2) estimated using the 2016 sample, the likelihood of adaptive device use increased significantly with the number of
vision-related limitations but not with family income (results not
shown). When the models were estimated with a subsample that excluded individuals with cataracts but no other age-related eye diseases,
the likelihood of adaptive device use increased substantially with income and significantly so when the sample was further limited to those
with multiple vision-related limitations (results not shown).

3. Results
3.1. Descriptive statistics
Table 1 presents weighted vision-related descriptive statistics for the
2008 and 2016 samples. 6.2% of the 2008 sample and 4.2% of the 2016
sample used adaptive devices; these percentages were significantly
different. Cataracts was the most common age-related eye disease in the
2008 and 2016 samples (85.3% and 88.7% of the respective samples).
17.0% of the 2008 sample and 18.1% of the 2016 sample had more
than one age-related eye disease. The proportion of each sample with
cataracts differed significantly between samples, but the proportions
with other age-related eye diseases did not. Difficulty reading was the
most common vision-related limitation in the 2008 and 2016 samples
(17.5% and 16.6% of the respective samples). 10.1% of the 2008
sample and 9.2% of the 2016 sample had multiple vision-related limitations and 31.4% of the 2008 sample and 24.0% of the 2016 sample
with multiple vision-related limitations used adaptive devices; these
percentages did not differ significantly between samples. Among those
with multiple vision-related limitations, the proportions of the 2008
and the 2016 samples that used adaptive devices differed significantly
for those with diabetic retinopathy but not for those with ARMD,
glaucoma or cataracts.
Table 2 presents weighted descriptive statistics for the full set of
explanatory variables for the 2008 sample and for subsamples defined

4. Discussion
The rate of adaptive device use in the 2008 and 2016 samples and
the subsamples of those with ARMD or diabetic retinopathy was substantially lower than that found in previous research (Becker et al.,
2005; Casten et al., 2005; Schmier et al., 2009; Schmier et al., 2006).
However, the prior research used samples of individuals with ARMD or
diabetic retinopathy who were patients at an ophthalmology clinic or
participated in an ARMD support group, and it is likely that individuals
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in these samples had more severe visual impairment than the individuals in the NHIS samples. This hypothesis is supported by the
finding that the rate of adaptive device use among individuals with
ARMD or diabetic retinopathy and multiple vision-related limitations in
the NHIS samples was similar to the previous studies that did not put a
restriction on the age of the individuals in the sample (Schmier et al.,
2009; Schmier et al., 2006). The difference in adaptive device use between the 2008 and 2016 samples, while statistically significant, is
small in percentage point terms. The difference is driven primarily by
the significantly higher prevalence of cataracts and the lower rate of
adaptive device use among individuals with cataracts in the 2016
compared to the 2008 sample.
Two important public health questions are: How many visually
impaired individuals in the U.S. could benefit from the use of adaptive
devices? and How much of this need is unmet? It is difficult to answer
these questions because the effects of a given vision condition on
functional ability can vary across individuals and the effects of vision
rehabilitation services and adaptive devices use can also vary across
individuals (Agency for Healthcare Research and Quality, 2004; Binns
et al., 2012; Morse et al., 2010; National Academies of Sciences,
Engineering and Medicine, 2016). However, there is established evidence that use of adaptive devices by visually impaired individuals can
improve functional reading ability and more recent evidence that use of
adaptive devices can improve visual information processing and visual
motor skills among individuals with macular disease (Binns et al., 2012;
Stelmack et al., 2017). Therefore, the low rate of adaptive device use in
both NHIS samples among those with an age-related eye disease who
reported difficulty reading and other vision-related limitations adds
support to the argument that public health strategies are needed to
increase access to adaptive devices in the U.S. (National Academies of
Sciences, Engineering and Medicine, 2016). More research is needed to
determine whether adaptive device use could improve a wider range of
functional abilities for a wider set of visually impaired individuals
(Binns et al., 2012; National Academies of Sciences, Engineering and
Medicine, 2016). Low vision rehabilitation is the primary means by
which visually impaired individuals are prescribed appropriate adaptive devices and trained in their use. However, very few individuals in
the NHIS samples reported receiving vision rehabilitation services at
the time of the surveys. This suggests that improving access to low vision rehabilitation services is likely to increase access to adaptive devices and improve visual ability. The development and evaluation of
public health strategies to achieve these goals are still in the early
stages and best practices have yet to be established (National
Academies of Sciences, Engineering and Medicine, 2016).
It should be a concern for public health if, among persons with
identical vision-related limitations and other functional limitations, the
use of adaptive devices differed with other individual or contextual
characteristics. Using data from 2008, this paper found consistent disparities by family income and the local availability of ophthalmologists
in adaptive device use among U.S. adults with age-related eye diseases.
The models using 2016 data suggest a similar pattern with respect to
family income among those with multiple vision-related limitations.
However, the 2016 results should be interpreted with caution because
the 2016 models did not include contextual variables.
The likelihood of adaptive device use was twice as high for the
highest income category as it was for the lowest income category in the
2008 regression models. Medicare does not cover adaptive devices that
contain lenses (Morse et al., 2010). Medicaid coverage of adaptive
devices varies by state and is limited in those states that do have coverage (Kaiser Commission on Medicaid and the Uninsured, 2012;
National Academies of Sciences, Engineering and Medicine, 2016).
Private health insurance often has coverage restrictions as well
(Institute of Medicine Committee on Disability in America, 2007;
National Academies of Sciences, Engineering and Medicine, 2016). A
potential explanation for the findings with respect to income is that
lower-income individuals were more likely to forgo adaptive devices

because of the difficulty of affording the out-of-pocket cost of these
devices. Additionally, given that eye care providers are the primary
source of referrals for vision rehabilitation services and that lower-income individuals tend to have more limited contact with eye care
providers than higher-income individuals, differences in visits to eye
care providers by income is another possible explanation for differences
in adaptive device use by income (Owsley et al., 2009; Zhang et al.,
2013; Zhang et al., 2012). There is a positive correlation between local
eye care provider availability and household income in the U.S.
(Gibson, 2015). However, given that the 2008 regression models include explanatory variables for local eye care provider availability, the
findings suggest that lower income individuals are less likely to visit a
given set of providers than higher income individuals.
Living in a county with fewer ophthalmologists per capita was associated with a significantly lower likelihood of adaptive device use in
the 2008 regression models. Owsley et al. (2009) surveyed entities that
provided vision rehabilitation services and found that almost half of
vision rehabilitation clients were referred for services by ophthalmologists and that referrals from other sources were substantially less
common. Gibson (2016) found that greater local ophthalmologist
availability was associated with a significantly increased likelihood of
having had a recent dilated eye exam among a sample of individuals
with ARMD, glaucoma, or cataracts and that the likelihood of having
lost vision due to an age-related eye disease declined as local ophthalmologist availability increased. The combination of these findings
and those of the current paper suggest that individuals with an agerelated eye disease who lived in a county with greater ophthalmologist
availability had more contact with ophthalmologists and as a result
were more likely to be referred for and receive vision rehabilitation
services and adaptive devices than individuals who lived in an area
with lower ophthalmologist availability.
A limitation of the paper that has not already been mentioned is that
information is not available from the NHIS surveys about the types of
adaptive devices that individuals used, whether the devices used were
the ones best suited to an individual's limitations, whether individuals
had been prescribed devices but abandoned them, the extent to which
individuals received training in and benefitted from the devices they
were using, and the distance to and capacity of local eye care and vision
rehabilitation service providers. An additional limitation is that adaptive device use and other individual characteristics were self-reported.
Despite these limitations, the paper has a number of strengths. One is
that it used two large samples of individuals with age-related eye diseases drawn from two separate waves of a nationally-representative
survey. Another is that the empirical analyses included detailed measures of an individual's vision-related limitations and other individual
characteristics and, for the 2008 sample, an extensive set of contextual
variables.
The rate of adaptive device use among U.S. adults with age-related
eye diseases was very low in the 2008 and 2016 samples, even among
individuals with vision-related limitations for which adaptive devices
have been found to improve functional ability. Furthermore, there were
differences in the use of adaptive devices by income and the local
availability of ophthalmologists, which provides additional evidence of
disparities in vision-related outcomes in the U.S. (National Academies
of Sciences, Engineering and Medicine, 2016; Zhang et al., 2013; Zhang
et al., 2012). These findings support the need for public health strategies to increase access to adaptive devices in the U.S.
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